Managing comorbidity: Tips and tricks for adapting practice in a changing environment
This webinar will provide a brief summary of comorbidity research, along with practical strategies to address comorbid mental health and substance use issues during the COVID-19 pandemic. Read more
Engaging with clients causing domestic and family violence harm during the COVID-19 pandemic
The COVID-19 pandemic presents new challenges and complexities in working with clients who perpetrate domestic and family violence (DFV). It is widely recognised that rates of DFV are increasing during this time, and that some perpetrators are expanding their tactics of coercive control. How might AOD services and practitioners help to keep those who are causing DFV harm within view, and identify and manage the risk they pose to family members? Read more
Participate in the opioid overdose response and take home Naloxone program
Watch this webinar to find out more about the Opioid Overdose Response and Take Home Naloxone program and how your organisation can become a registered provider of Take Home Naloxone. Read more
Clinical incident management
Under AOD-Core KPI 4 Clinical Incident Management, organisations are required to have a clinical incident management process in place to manage all clinical incidents, and to report serious clinical incidents. Read more
Engaging with families and significant others
Learn how to engage with families and significant others of people with substance use issues. Read more
Depot buprenorphine is a new long acting formulation of an existing opioid pharmacotherapy, buprenorphine and is available now in specialist OST clinics and NSW Government run prisons. Learn more about how this pharmacotherapy works and discuss the implications for people who receive this treatment.
Presenters: Dr Suzie Hudson (NADA) and NSW Chief Addiction Medicine Specialist, Dr Tony Gill.